SAT0281 Comparison of the Efficacy and Safety of Zoledronic Acid Taken Once a Year in the Treatment of Postmenopausal and Glicocorticosteroid-Inducted Osteoporosis in the Course of Connective Tissue Disease – 5 Year Observation

Abstract

BackgroundZoledronic acid (ZA) is approved to prevent or treat osteoporosis in women after menopause (PO), men, secondary osteoporosis, especially glicocorticoid-inducted one (GC). Causes of osteoporosis in patients with connective tissue...